Opass Putcharoen

1.5k total citations
47 papers, 546 citations indexed

About

Opass Putcharoen is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Opass Putcharoen has authored 47 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 12 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Opass Putcharoen's work include HIV/AIDS drug development and treatment (13 papers), SARS-CoV-2 and COVID-19 Research (11 papers) and COVID-19 Clinical Research Studies (11 papers). Opass Putcharoen is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), SARS-CoV-2 and COVID-19 Research (11 papers) and COVID-19 Clinical Research Studies (11 papers). Opass Putcharoen collaborates with scholars based in Thailand, United States and Australia. Opass Putcharoen's co-authors include Kiat Ruxrungtham, Anchalee Avihingsanon, Daniel R. Kuritzkes, Watsamon Jantarabenjakul, Sivaporn Gatechompol, Leilani Paitoonpong, Supaporn Wacharapluesadee, Nattiya Hirankarn, Thanyawee Puthanakit and Gompol Suwanpimolkul and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Opass Putcharoen

43 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Opass Putcharoen Thailand 13 429 119 100 49 41 47 546
Sumonmal Uttayamakul Thailand 10 329 0.8× 112 0.9× 107 1.1× 23 0.5× 45 1.1× 22 495
Neeraj Nischal India 10 399 0.9× 209 1.8× 24 0.2× 42 0.9× 55 1.3× 71 590
Dan Ouchi Spain 15 425 1.0× 149 1.3× 342 3.4× 73 1.5× 78 1.9× 50 781
Pasquale De Nardo Italy 14 288 0.7× 154 1.3× 29 0.3× 22 0.4× 44 1.1× 36 634
Héloïse Delagrèverie France 12 276 0.6× 76 0.6× 131 1.3× 22 0.4× 114 2.8× 18 469
Fizza S. Gillani United States 15 429 1.0× 318 2.7× 99 1.0× 46 0.9× 20 0.5× 51 556
Inés Suárez‐García Spain 10 214 0.5× 123 1.0× 22 0.2× 26 0.5× 13 0.3× 34 411
Jorge Villacian Singapore 14 495 1.2× 210 1.8× 286 2.9× 36 0.7× 86 2.1× 21 800
Peter Messiaen Belgium 13 381 0.9× 133 1.1× 188 1.9× 58 1.2× 123 3.0× 39 631
Tulika Singh United States 12 228 0.5× 130 1.1× 60 0.6× 55 1.1× 18 0.4× 39 480

Countries citing papers authored by Opass Putcharoen

Since Specialization
Citations

This map shows the geographic impact of Opass Putcharoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Opass Putcharoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Opass Putcharoen more than expected).

Fields of papers citing papers by Opass Putcharoen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Opass Putcharoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Opass Putcharoen. The network helps show where Opass Putcharoen may publish in the future.

Co-authorship network of co-authors of Opass Putcharoen

This figure shows the co-authorship network connecting the top 25 collaborators of Opass Putcharoen. A scholar is included among the top collaborators of Opass Putcharoen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Opass Putcharoen. Opass Putcharoen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Putcharoen, Opass, et al.. (2024). Prevalence and incidence rates of tuberculosis in people with HIV during the coronavirus 2019 pandemic: a single center retrospective analysis. SHILAP Revista de lepidopterología. 25(1). 2348935–2348935. 2 indexed citations
2.
Wacharapluesadee, Supaporn, Spencer L. Sterling, Kirana Noradechanon, et al.. (2024). Comparative Performance in the Detection of Four Coronavirus Genera from Human, Animal, and Environmental Specimens. Viruses. 16(4). 534–534. 2 indexed citations
3.
Doungngern, Pawinee, Spencer L. Sterling, Chonticha Klungthong, et al.. (2024). An unusual diarrheal outbreak in the community in Eastern Thailand caused by Norovirus GII.3[P25]. Virology Journal. 21(1). 21–21. 5 indexed citations
4.
Torvorapanit, Pattama, et al.. (2023). Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand. Journal of Pharmaceutical Policy and Practice. 16(1). 29–29. 4 indexed citations
5.
Wacharapluesadee, Supaporn, Pattama Torvorapanit, Rome Buathong, et al.. (2023). Simultaneous detection of omicron and other SARS-CoV-2 variants by multiplex PCR MassARRAY technology. Scientific Reports. 13(1). 2089–2089. 7 indexed citations
6.
Buathong, Rome, Taweewun Hunsawong, Supaporn Wacharapluesadee, et al.. (2022). Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants. Vaccines. 10(8). 1321–1321. 4 indexed citations
7.
Katavetin, Pisut, et al.. (2022). Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study. SHILAP Revista de lepidopterología. 23(1). 99–106. 2 indexed citations
8.
9.
Putcharoen, Opass, et al.. (2022). Use of qRT-PCR for SARS-CoV-2 sgRNA leader for the therapeutic plan: a preliminary report on 10 patients. The Journal of Infection in Developing Countries. 16(4). 604–607. 1 indexed citations
10.
Buathong, Rome, Sopon Iamsirithaworn, Supaporn Wacharapluesadee, et al.. (2021). Multiple clades of SARS‐CoV‐2 were introduced to Thailand during the first quarter of 2020. Microbiology and Immunology. 65(10). 405–409. 5 indexed citations
11.
Putcharoen, Opass, Supaporn Wacharapluesadee, Wan Ni Chia, et al.. (2021). Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand. PLoS ONE. 16(2). e0246864–e0246864. 17 indexed citations
12.
Gatechompol, Sivaporn, Anchalee Avihingsanon, Opass Putcharoen, Kiat Ruxrungtham, & Daniel R. Kuritzkes. (2021). COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Research and Therapy. 18(1). 28–28. 61 indexed citations
13.
Tungsanga, Somkanya, Pattama Torvorapanit, Suwasin Udomkarnjananun, et al.. (2020). A case of successful treatment of severe COVID‐19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient. Transplant Infectious Disease. 23(1). e13388–e13388. 32 indexed citations
14.
15.
Siwamogsatham, Sarawut, Aurauma Chutinet, Opass Putcharoen, et al.. (2019). Low CD4 Cell Counts Are Associated with Carotid Plaque and Intima–Media Thickness in Virologically Suppressed HIV-Infected Asians Older Than 50 Years. AIDS Research and Human Retroviruses. 35(11-12). 1160–1169. 6 indexed citations
16.
Rerknimitr, Pawinee, et al.. (2017). Subcutaneous Saksenaea vasiformis infection presenting as disfiguring facial plaques. Indian Journal of Dermatology Venereology and Leprology. 83(3). 346–346. 3 indexed citations
17.
Putcharoen, Opass, Lalita Wattanachanya, Jiratchaya Sophonphan, et al.. (2017). New-onset diabetes in HIV-treated adults. AIDS. 31(11). 1535–1543. 33 indexed citations
18.
Sirivichayakul, Sunee, et al.. (2014). Rilpivirine versus etravirine validity in NNRTI‐based treatment failure in Thailand. Journal of the International AIDS Society. 17(4S3). 19740–19740. 3 indexed citations
19.
Kerr, Stephen J., Anchalee Avihingsanon, Opass Putcharoen, et al.. (2012). Assessing adherence in Thai patients taking combination antiretroviral therapy. International Journal of STD & AIDS. 23(3). 160–165. 15 indexed citations
20.
Permpalung, Nitipong, Opass Putcharoen, Anchalee Avihingsanon, & Kiat Ruxrungtham. (2012). Treatment of HIV infection with once-daily regimens. Expert Opinion on Pharmacotherapy. 13(16). 2301–2317. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumonmal Uttayamakul Breakdown of academic impact, for papers by Neeraj Nischal Breakdown of academic impact, for papers by Dan Ouchi Breakdown of academic impact, for papers by Pasquale De Nardo Breakdown of academic impact, for papers by Héloïse Delagrèverie Breakdown of academic impact, for papers by Fizza S. Gillani Breakdown of academic impact, for papers by Inés Suárez‐García Breakdown of academic impact, for papers by Jorge Villacian Breakdown of academic impact, for papers by Peter Messiaen Breakdown of academic impact, for papers by Tulika Singh
Rankless by CCL
2026